The poster is the first step in a long journey ATH has no money to take a single step. It demonstrates that even in genetic problems there may be possibilities with safe iron chelators. Perhaps FA societies will come to help to get a clinical study started. An open study would work with only a few patients. ATH434 needs to be approved before any FA patients can be tested.
The poster is the first step in a long journey ATH has no money...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $5.87K | 1.260M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 58 | 78543711 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 19897519 | 17 |
View Market Depth
| Last trade - 16.10pm 11/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 25.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 188888 | ||
| Last updated 12.51pm 11/06/2024 ? | |||||
| ATH (ASX) Chart |